SS
SPRY icon

SBI Securities’s ARS Pharmaceuticals SPRY Stock Holding History

SBI Securities’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.22K Sell
650
-99
-13% -$949 ﹤0.01% 2010
2025
Q4 		$8.73K Buy
749
+51
+7% +$496 ﹤0.01% 1777
2025
Q3 		$7.01K Buy
698
+48
+7% +$689 ﹤0.01% 1915
2025
Q2 		$11.3K Sell
650
-7
-1% -$101 ﹤0.01% 1649
2025
Q1 		$8.27K Sell
657
-15,896
-96% -$191K ﹤0.01% 1683
2024
Q4 		$175K Buy
+16,553
New +$232K 0.01% 583

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return